Valuation: Guerbet

Market Cap 102M 117M 94.78M 87.17M 165M 11.16B 166M 1.11B 437M 5.59B 441M 431M 18.5B P/E 2026 *
-4.52x
P/E 2027 * 8.77x
Enterprise Value 477M 551M 445M 409M 773M 52.4B 781M 5.23B 2.05B 26.22B 2.07B 2.02B 86.83B EV / Sales 2026 *
0.62x
EV / Sales 2027 * 0.59x
Free-Float
36.58%
Yield 2026 *
-
Yield 2027 * 2.89%
1 day+12.28%
1 week+5.88%
Current month+2.44%
1 month-10.11%
3 months-31.77%
6 months-41.85%
Current year-46.38%
1 week 7.38
Extreme 7.38
7.56
1 month 7.05
Extreme 7.05
8.72
Current year 7.05
Extreme 7.05
14.92
1 year 7.05
Extreme 7.05
22.75
3 years 7.05
Extreme 7.05
39.4
5 years 7.05
Extreme 7.05
43.65
10 years 7.05
Extreme 7.05
89.68
Manager TitleAgeSince
Chief Executive Officer - 02/02/2026
Chief Executive Officer - 22/09/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 44 29/05/2015
Director/Board Member 50 19/05/2017
Director/Board Member 51 22/11/2023
Change 5-day change 1-year change 3-year change Capi.($)
+12.28%+5.88% - - 117M
-1.30%-0.92%-12.15%-16.57% 13.72B
+3.87%+4.46%+48.05%-2.62% 4.18B
-0.82%+5.74%-36.89%-52.60% 1.3B
-3.13%+8.48%-33.24%-40.07% 1.23B
-1.36%-2.55%+32.04%+89.71% 1.17B
-1.11%+2.71%-45.72% - 961M
+14.85%+16.29%+30.56%+126.54% 543M
-2.45%+2.11%+63.53% - 338M
-0.24%-3.25%-60.99%+226.66% 257M
Average +2.06%+5.83%-1.65%+47.29% 2.63B
Weighted average by Cap. -0.03%+1.57%-1.62%-5.51%

Financials

2026 *2027 *
Net sales 764M 882M 712M 655M 1.24B 83.86B 1.25B 8.37B 3.28B 41.96B 3.31B 3.24B 139B 798M 922M 744M 684M 1.29B 87.64B 1.31B 8.74B 3.43B 43.85B 3.46B 3.39B 145B
Net income -35.8M -41.33M -33.37M -30.69M -57.94M -3.93B -58.59M -392M -154M -1.97B -155M -152M -6.51B 8.3M 9.58M 7.74M 7.12M 13.43M 911M 13.58M 90.92M 35.68M 456M 35.99M 35.2M 1.51B
Net Debt 376M 434M 350M 322M 608M 41.24B 615M 4.11B 1.61B 20.63B 1.63B 1.59B 68.33B 370M 428M 345M 317M 599M 40.66B 606M 4.06B 1.59B 20.34B 1.61B 1.57B 67.37B
Logo Guerbet
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (54.4%); - MRI products (32.1%); - other (13.5%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2024 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Net sales are distributed geographically as follows: Europe/Middle East/Africa (43.8%), Americas (29.7%) and Asia (26.5%).
Employees
2,700
Date Price Change
06/08/26 7.560 +0.40%
05/08/26 €7.530 +0.80%
04/08/26 €7.470 -0.53%
03/08/26 €7.510 +1.76%
31/07/26 €7.380 +3.36%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
3
Last Close Price
8.060EUR
Average target price
8.433EUR
Spread / Average Target
+4.63%

Quarterly revenue - Rate of surprise